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Abstract Increasing attention has been paid to the effects of 
hypoxia, heavy metals and heat shocks on gene expression and to 
the similarities in their actions. This paper compares mRNA 
levels of two putative hypoxia, heavy metal and heat shock 
sensitive genes: heine oxygenase-1 (HO-1) and vascular 
endothelial growth factor (VEGF) in myocyte-enriched cultures 
of neonatal rat heart cells. HO-1 mRNA expression is stimulated 
by hemin, Cd 2÷, Co 2+ and heat shocks but not by Ni 2+ or Mn 2+. 
It is stimulated by long (13 h) but not by short (4 h) periods of 
anoxia. Conversely, VEGF mRNA expression is stimulated by 
short as well as long periods of anoxia, by Cd 2+, Co 2+, Ni 2+ and 
Mn 2+ but not by hemin or heat shocks. The results suggest hat 
heavy metals, anoxia and heat shocks exert their effects on 
VEGF and HO-1 mRNA expression through separate though 
potentially overlapping mechanisms. Increased expressions of 
HO-1 and VEGF may be both cardioprotective under hypoxic! 
ischemic conditions. 
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1. Introduction 
Increasing evidence suggests that mammalian cells sense 
their oxygen environment and adapt to it by changing their 
pattern of gene expression. Examples of hypoxia regulated 
genes are erythropoietin [1], vascular endothelial growth fac- 
tor (VEGF) [2,3], enzymes of the glycolytic pathway [4-6], 
heme oxygenase-1 (HO-1) [7,8], heat shock proteins [9] and 
tyrosine hydroxylase [10]. 
Among these hypoxia sensitive genes, HO-1 and VEGF are 
expressed in cardiac tissues [2,3,7,11] and are of particular 
importance for protecting hearts against hypoxia. HO-1 (EC 
1.14.99.3) catalyses the initial reaction in heme catabolism: 
the oxidative cleavage of the a-mesocarbon bridge of b-type 
heme molecules to yield equimolar quantities of biliverdin 
IXa, carbon monoxide and iron. Carbon monoxide is a potent 
activator of soluble guanylate cyclase [12] and vasodilator 
substance [13]. VEGF is a potent and specific endothelial 
cell mitogen. It probably plays an important role in the for- 
mation of tumor associated vasculature [14] and has been 
shown to induce collateral vessel development in a rabbit 
model of hind limb ischemia [15]. 
Circumstantial evidence suggests that HO-1 and VEGF ex- 
pressions are regulated by similar if not identical mechanisms. 
In non-cardiac tissues, HO-1 is induced in different situations 
of stress such as oxidative damage, heat shock and UVA 
radiation [16], by heavy metals such as Cd 2+ and Co 2+ and 
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by its substrate hemin [17,18]. It is induced by hypoxia in rat 
hearts [7] and Chinese hamster ovary cells [8]. Conversely, 
cardiac VEGF expression is stimulated by hypoxia and 
Co 2+ [2,3,11,19]. 
To analyze further the mechanisms involved in these regu- 
lations, this study compares VEGF and HO-1 mRNA expres- 
sions by myocyte-enriched cultures of new born rat heart cells 
exposed to anoxia, heat shocks and to heavy metals. 
2. Materials and methods 
2.1. Chemicals 
All enzymes and tissue culture media were from Gibco BRL unless 
specified. Radioactive materials were from ICN. Fetal calf serum was 
from Boehringer and horse serum from D. Dutcher (Strasbourg, 
France). All chemicals were from Sigma. 
2.2. Cell culture 
Myocyte-enriched cultures were prepared from new born rats as 
previously described [20]. Cells were grown on gelatin-coated dishes 
for 3 days in Ham's FI2 medium supplemented with 2 mM glutamine, 
10% heat inactivated fetal bovine serum and 10% heat inactivated 
horse serum. After washing, cells were further incubated for 24 h 
into a 2% serum culture medium and then exposed for 4 h (unless 
otherwise indicated) to different experimental conditions. A low serum 
condition was used to decrease the endogenous expression of VEGF 
mRNAs due to activation of serum responsive lements observed 
when 10% serum was used [3]. Anoxic conditions were induced by 
incubating cells (in a 10 mM HEPES-buffered and bicarbonate-free 
medium) for 4 h in an air tight container flushed with pure N2 [3]. A 
heat shock was produced by exposing cells to 41°C for 4 h. 
cGMP measurements were performed using the Amersham assay 
kit according the instructions of the manufacturer. Cells were exposed 
to 100 laM hemin or to 41°C for 4 h in the presence of 0.1 mM 
isobutyl methyl xanthine. 
2.3. Northern blots 
Total RNA was extracted according to Chomczynski and Sacchi 
[21]. 10 gg of total RNA were fractionated by denaturing electrophor- 
esis on 1.2% agarose formaldehyde gels and transferred to Nytran 
membranes (Schleicher and Schuell) prior to hybridisation with se- 
lected probes. The rat HO-1 probe was a 159 base pair fragment 
comprised between ucleotides 436 and 595 of the coding sequence. 
It was generated by polymerase chain reaction from mRNA isolated 
from Co 2+ treated cardiac myocytes [22]. The rat VEGF probe was a 
350 base pair fragment comprised between ucleotides 168 and 517 of 
rat VEGF 164 [23]. PCR products were subcloned into the Smal site 
of bluescript SK(--) plasmids (Stratagene) and sequenced by the di- 
deoxy terminator sequencing kit (Applied Biosystem). Glyceralde- 
hyde-3-phosphate d hydrogenase (GAPDH) probe was a gift of Dr. 
F. Moreau-Gachelin (Paris). cDNA probes were labelled using 
[a2p]dCTP and the Prime-a-Gene labeling system (Promega). Autora- 
diography was performed with intensifying screens at -80°C using 
Kodak X-Omat AR films. Relative amounts of radiolabelled cDNA 
that hybridized to the blots were quantitated using the NIH image 
software and normalized to GAPDH mRNA levels to control for 
loading errors. VEGF/GAPDH and HO-1/GAPDH signal ratio 
were set at an arbitrary value of 1 in control experiments. 
Means + S.E.M. (n > 3) are indicated. 
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Fig. 1. Hemin stimulates HO-1 mRNA expression. Left: Dose dependent accumulation of HO-1 mRNA in hemin stimulated cells. Cardiomyo- 
cytes were incubated for 4 h with the indicated concentrations of hemin and Northern blots hybridized with HO-1, VEGF and GAPDH probes 
as indicated. Right: Dose response curve for hemin action on normalized HO-1 (e) and VEGF ((3) hybridization signals. 
3. Results 
Cardiomyocyte-enriched cultures of new born rat heart cells 
were prepared and exposed to different experimental condi- 
tions known to alter HO-1 or VEGF gene expressions in other 
cell types. RNA was extracted and analyzed by Northern 
blots, All hybridization signals were normalized to that of 
GAPDH. 
Hemin, the substrate of HO-1, is known to induce HO-I 
expression i  other tissues [18]. Unstimulated rat cardiomyo- 
cytes expressed low levels of HO-1 and VEGF mRNAs. Ex- 
posing cardiac cells to hemin induced a large (up to 27 fold) 
increase in HO-1 mRNA levels (Figure 1). Induction was al- 
ready detected after 1 h of exposure to 100 jaM hemin and 
was maximum at 6 h (data not shown). The action of hemin 
developed at concentrations between 1 and 100 gM. Under 
identical conditions, hemin exerted no significant action on 
VEGF mRNA levels (Fig. 1). 
Neonatal cardiomyocytes mainly rely on glycolysis to main- 
tain high intracellular ATP levels. They can be maintained 
under anoxic conditions for several hours without impairing 
spontaneous contractile activity [24]. Fig. 2 shows that a 4 h 
anoxia increased 5 fold VEGF mRNA levels. It had no sig- 
nificant influence on HO-1 mRNA levels. More prolonged 
anoxic periods increased both HO-1 and VEGF mRNA 
levels. In these series of experiments and after correcting for 
loading, anoxia increased the VEGF hybridization signal up 
to 8 fold. It increased the HO-1 hybridization signal only 
2 fold. More prolonged anoxic periods led to erratic results 
and were associated with extensive cell damage. Thus, VEGF 
mRNA expression i  response to anoxia appeared sooner and 
was more pronounced than that of HO-1. 
We next compared the actions of heavy metals on HO-1 
and VEGF mRNA expressions. Heavy metals such as Co 2+, 
Ni 2+ and Mn 2+ are thought o induce VEGF gene expression 
by activating hypoxia sensitive lements [2]. Cd 2+ and Co 2+ 
increase HO-1 gene expression via well identified metal re- 
sponsive lements [25], 
Fig. 3 shows that Co 2+ induced increased expressions of 
both VEGF and HO-1 mRNAs. Its action on HO-1 mRNA 
expression was already detected after 1 h and reached a max- 
imum at 2-4 h, similar to what has been observed with VEGF 
[11]. Dose response curves were, however, markedly different. 
A statistically significant action of Co 2+ on VEGF mRNA 
expression was only observed at 30 gg/ml COC12 (correspond- 
ing to 230 gM Co 2+) and the maximum stimulation observed 
was only 2 fold. Higher concentrations led to more erratic 
results. When data from different experiments were pooled, 
no statistically significant increase in VEGF mRNA expres- 
sion was observed at 50 or 100 gg/ml COC12. Fig. 3 shows that 
Co 2+ increased HO-1 mRNA expression i  a dose-dependent 
manner and that the maximum stimulation produced at 100 
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Fig. 2. Anoxia induces VEGF and HO-1 mRNA expressions. Left: Representative Northern blots showing the action of 4 h and 13 h anoxia 
on VEGF and HO-1 mRNA levels. Right: Normalized HO-1 and VEGF hybridization signals. *P < 0.01 as compared to controls. 
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Fig. 3. Cobalt stimulates HO-1 mRNA expression. Left: Representative Northern blots showing the actions of 230 gM CO 2+ on VEGF and 
HO-1 mRNAs. Right: Dose response curve for Co 2+ action on HO-1 hybridization signal. Its action on the VEGF signal (2 fold increase) was 
too low to be represented onthe same scale. 
gg/ml reached 46 fold. This action of Co 2+ was completely 
prevented by actinomycin D (5 p.g/ml) and by cycloheximide 
(10 gg/ml) (data not shown). Thus, Co 2+ was a strong inducer 
of HO-I mRNA expression. It was a much weaker inducer of 
VEGF mRNA expression. 
We next examined the action of Cd 2+, a potent inducer of 
HO-1 mRNA expression [18]. Fig. 4 shows that Cd 2+ in- 
creased HO-1 mRNA levels in rat cardiomyocytes. Induction 
was already detected after 1 h and reached a maximum at 2-4 
h. It developed at low micromolar concentrations (Fig. 4). In 
the same cells, Cd 2+ also increased VEGF mRNA levels with 
a similar time course. VEGF mRNA expression was, how- 
ever, less sensitive to the action of Cd 2÷ than that of HO-1 
(Fig. 4). After normalization of the hybridization signal, Cd 2÷ 
increased HO-1 mRNA levels 10 fold. It increased VEGF 
mRNA levels only 4 fold. 
Ni 2+ and Mn 2+ (100 p.M) increased VEGF mRNA levels 
about 2 fold in cardiomyocytes [11]. They had no significant 
action on HO-1 mRNA expression (data not shown). 
Fig. 5 shows that a heat shock increased HO-1 mRNA 
expression 4 fold. It had no action on VEGF mRNA levels. 
HO-1 generates carbon monoxide, a potent agonist of so- 
luble guanylate cyclase [12]. An obvious question raised by 
our experiments was whether induction of HO-1 mRNA ex- 
pression led to cGMP formation. No effect of heat shock and 
hemin (100 gM) on cGMP levels was observed in cultured 
cardiomyocytes. We also observed that the cells used did 
not respond to 0.1 mM sodium nitroprusside by the formation 
of cGMP, hence indicating that they probably lack soluble 
guanylate cyclase activity. 
4. Discussion 
Expression of HO-1 mRNAs in cardiomyocytes is strongly 
enhanced by hemin, Co 2+ and Cd 2+. It is moderately en- 
hanced by hypoxia and heat shocks. This pattern of regula- 
tion is similar to that described in other cell types [8,16-18]. 
Expression of VEGF mRNAs is similar in many respects to 
that of HO-1 but differs substantially. VEGF mRNA expres- 
sion is stimulated by hypoxia, Co 2+ and Cd 2+ but not by 
hemin or heat shocks. 
Studies derived from the erythropoietin field suggest hat 
Co 2+ acts by replacing Fe 2+ in the heme molecule associated 
with putative hypoxia sensitive transcription factors and by 
locking them into an active deoxy form [1]. The observation 
that Co 2+ mimics the effects of hypoxia on VEGF mRNA 
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Fig. 4. Cadmium stimulates HO-1 and VEGF mRNA expressions: Left: Representative Northern blots showing the time course of action of 
10 gM Cd 2÷ on VEGF and HO-1 mRNA expressions. Right: Dose response curves for Cd 2+ action on normalized HO-1 (O) and VEGF (©) 
mRNA levels. Time of exposure to Cd 2+ was 4 h. 
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Fig. 5. Heat shock activates HO-1 but not VEGF mRNA expression: Left: Representative Northern blot showing the actions of 4 h exposures 
to 41°C on HO-1, VEGF and GAPDH mRNA expressions. Right: Normalized HO-1 and VEGF hybridization signals. *P < 0.01 as compared 
to controls. 
expression has been taken as strong evidence in favor of the 
hypothesis that an oxygen sensor controls VEGF gene expres- 
sion in a manner independent of the energetic state of the cells 
[2,11]. The difficulty with this hypothesis i that the specificity 
of Co 2+ has not been demonstrated. A first action of heavy 
metals could be to block L-type Ca 2+ channels [26]. The ob- 
servations that VEGF [11] and HO-1 (data not shown) 
mRNA expressions are not affected by 0.1 gM PN 200-110, 
a potent blocker of L-type Ca 2+ channels uggest hat actions 
of heavy metals reported here were unlikely associated to an 
impaired excitability. Another action of heavy metals is to 
activate gene transcription by acting via hypoxia sensitive le- 
ments [27] (that are present in the VEGF gene but not in the 
HO-1 gene) or via metal responsive lements that have been 
characterized in the metallothionein [28] and HO-1 genes [25]. 
The observations that Cd 2+ and Co 2+ increase HO-1 mRNA 
expression (Figs. 3 and 4) indicate that heavy metals enter 
cardiomyocytes via yet unidentified pathways and are able 
to activate directly or indirectly metal responsive lements in 
the HO-1 gene promoter. Analysis of the VEGF gene se- 
quence shows the presence both of putative metal responsive 
elements (homologous to those present in the HO-1 gene) and 
of functional hypoxia sensitive elements [27]. An obvious 
question is therefore whether heavy metals induce VEGF 
mRNA expression by activating metal responsive lements 
or hypoxia sensitive lements. The close similarities between 
heavy metal actions on VEGF and HO-I mRNA expressions 
suggest that they act via metal responsive lements rather than 
via hypoxia sensitive elements. Although further analysis is 
required to ascertain that putative metal responsive lements 
present in the VEGF gene are functional, this hypothesis is 
consistent with recent results showing that in human retinal 
pigment cells Co 2+ increases VEGF mRNA expression by a 
mechanism distinct from hypoxia [29]. 
Expression of both VEGF and HO-1 mRNAs are stimu- 
lated in response to anoxia but with different sensitivities. 
(i) Expression of HO-1 mRNAs is delayed by several hours 
as compared to that of VEGF. (ii) Long periods of anoxia 
induce larger increases in VEGF mRNA levels (8 fold) than of 
HO-1 mRNA levels (2 fold) (Fig. 2). These could suggest 
anoxia acts by more than one type of mechanism. VEGF 
expression is thought o be determined by an oxygen sensor, 
independent of the energetic state of the cells [2]. Conversely, 
HO-1 expression by human skin fibroblasts is thought to be 
determined by the availability of cellular glutathione [16]. It 
should be noted, however, that in isolated perfused hearts, 
induction of VEGF mRNA expression by hypoxia is slowed 
down when contractile activity is arrested with tetrodotoxin 
[19]. This suggests that energy dependent mechanisms also 
determine VEGF mRNA expression at least in intact hearts. 
HO-1 is considered as a heat shock protein [18,30,31]. In 
agreement, HO-1 mRNA expression is induced by hyperther- 
mia in isolated rat hearts [32] and by heat shocks in cultured 
neonatal cardiomyocytes (Fig. 5). Increasing evidence suggests 
that hypoxia induces the expression of heat shock proteins 
and that hypoxia and heat shock act via similar if not iden- 
tical mechanisms [9,33]. Our results how that this is probably 
not true in cardiac cells. HO-1 mRNA expression is clearly 
increased after a heat shock; that of VEGF is not (Fig. 5). 
Taken together, these results stress the point that although 
heavy metals, hypoxia and heat shocks control the expression 
of similar sets of genes, they may act through separate, 
though potentially overlapping pathways. 
Increased expression of both VEGF and HO-1 may be an 
important adaptative mechanism to improve blood flow under 
chronic hypoxic/ischemic conditions. VEGF is a potent angio- 
genic factor that induces the formation of neovessels in is- 
chemic states [14,15]. HO-1 on the other hand generates bile 
pigments that act as radical scavengers [34]. It also produces 
carbon monoxide, a potent agonist of soluble guanylyl cyclase 
and vasodilator substance [12,13]. It is of interest hat hy- 
perthermia which increases HO-1 expression also induces the 
formation of cGMP in intact hearts [32]. This is not true in 
cultured cells. All treatments that induce HO-1 mRNA ex- 
pression in cultured cardiomyocytes do not increase cellular 
GMP levels probably because cells lack soluble guanylate 
cyclase. It could be that in intact hearts, carbon monoxide 
produced by HO-1 mainly acts in a paracrine manner to 
activate soluble guanylate cyclase in the coronary vascul- 
ature. 
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